CLINDAMYCIN HYDROCHLORIDE CAPSULES

The Defense Logistics Agency awarded a delivery order under the parent IDIQ contract SPE2DX25D8022 to Cardinal Health, Inc. (CAGE 00E55) on July 15, 2026, for the procurement of 2 bottles of Clindamycin Hydrochloride Capsules (NSN 6505001594892) at a total price of $25.46. This order is part of a larger $20 million indefinite-delivery/indefinite-quantity contract managed by DLA Troop Support, Medical Supply Chain FSB in Philadelphia, PA, with payment processed through the Defense Finance and Accounting Service in Columbus, OH. The acquisition falls under NAICS code 424210 for wholesale of drugs and druggists’ sundries, with no socioeconomic set-aside and classified as unrestricted. The contract type is Firm Fixed Price through incorporation of FAR clauses 52.212-4 and 52.212-5, reflecting its commercial items procurement framework, and delivery is FOB destination to the DLA medical supply chain facility in Philadelphia, with the awardee’s facility in Dublin, OH serving as the place of performance. Packaging and marking must comply with military standards implied by FLEET MILSTRIP protocols, including MIL-STD-129 for labeling and MIL-STD-2073 for preservation, with freight labeled with tracking identifiers such as N215256196S403 and RDD: 777. Inspection and acceptance occur at the destination by the government, with full compliance required under contract terms. Invoicing must be submitted electronically or via Standard Form 1449 to the designated payment office, and remittance is sent to Cardinal Health’s address in Dublin, OH. The contracting officer is Lorinda Ferraiolo, with administrative support from Catherine Gilbert and Michelle Pampel; no formal COR or COTR is designated in the documentation. The order carries no option quantities or price variance, and while the base value is minimal, it operates within the context of a high-value parent contract supporting medical supply chain operations across the Department of Defense.